Welcome to the Investor Relations section of CareFusion’s website. Here, we provide access to a variety of shareholder materials, including financial and stock information, corporate governance resources and access to our presentations and events. We are committed to providing you with convenient access to these resources, and if you need additional information, please contact us.
You can also sign up to receive email alerts when new company information is available by going to CareFusion’s Email Alerts page.
To receive printed copies of CareFusion investor materials by mail, you can submit an on-line request here. You may also send an email to email@example.com with your contact information and material request.
CareFusion (NYSE: CFN) is a global corporation serving the health care industry with products and services that help hospitals measurably improve patient care. The company develops market-leading technologies including Alaris® infusion pumps, Pyxis® automated dispensing and patient identification systems, AVEA® and LTV® series of ventilators and respiratory products, ChloraPrep® skin prep products, MedMined™ services for data mining surveillance, and V. Mueller® and Snowden-Pencer® surgical instruments.
|There are currently no events scheduled.|
View all of CareFusion’s Events & Presentations.
Annual Meeting and Proxy Information
Learn more about CareFusion Annual Meeting of Stockholders and access our Annual Report and Proxy Statement here.
Access more detailed stock information.
|11/20/14||Becton Dickinson And CareFusion Announce Expiration Of HSR Act Waiting Period In Proposed Transaction|
|FRANKLIN LAKES, N.J. and SAN DIEGO, Nov. 20, 2014 /PRNewswire/ -- Becton, Dickinson and Company (NYSE: BDX) ("BD") and CareFusion Corporation (NYSE: CFN) ("CareFusion") today announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the "HSR Act"), in connection with BD's proposed acquisition of CareFusion expired on November 19, 2014.
As previously announced on October 5, 2014, BD and CareFusion entered into a definitive agreement pursua... |
|11/06/14||CareFusion Reports First Quarter Fiscal 2015 Results|
|- Revenue increased 11 percent to $922 million
- Diluted earnings per share (EPS) from continuing operations totaled $0.37 on a GAAP basis and increased 14 percent from the prior year period to $0.50 per adjusted share
- Company increases fiscal 2015 adjusted diluted EPS guidance range to $2.80 to $2.95, driven primarily by a second quarter tax settlement with the Internal Revenue Service
SAN DIEGO, Nov. 6, 2014 /PRNewswire/ -- CareFusion Corp. (NYSE: CFN), a leading, global medical tec... |
|10/05/14||BD to Acquire CareFusion for $12.2 Billion|
|Combination of Complementary Portfolios Creates Global Leader in Medication Management and Patient Safety Solutions.
Franklin Lakes, NJ and San Diego, CA (October 5, 2014) – BD (NYSE: BDX) and CareFusion (NYSE: CFN) announced today a definitive agreement under which BD will acquire CareFusion for $58.00 per share in cash and stock, or a total of $12.2 billion, to create a global leader in medication management and patient safety solutions. The agreement has been unanimously approve... |
|08/07/14||CareFusion Reports Fourth Quarter And Fiscal 2014 Results|
|- Fourth quarter revenue of $1.12 billion, up 24 percent; Fiscal 2014 revenue of $3.84 billion, up 8 percent.
- Fourth quarter GAAP diluted earnings per share (EPS) from continuing operations increased 37 percent to $0.67, or up 44 percent to $0.79 on an adjusted basis.
- Fiscal 2014 GAAP diluted EPS from continuing operations increased 13 percent to $1.96, or up 11 percent to $2.36 on an adjusted basis.
- Company expects fiscal 2015 adjusted diluted EPS in the range of $2.60 to $2.75; ... |
Read all of
CareFusion’s financial news releases.
Read CareFusion’s news releases.
Cautions Concerning Forward-Looking Statements: This website contains statements that are forward-looking and consequently are subject to risks and uncertainties. Examples of these statements include statements regarding our financial guidance, our expectations regarding hospital capital spending, our expected standup costs and other costs related to the separation from Cardinal Health and other statements regarding matters that are not historical facts. You should be aware that certain factors may affect us in the future and could cause actual results to differ materially from those expressed in these forward-looking statements. Such factors include the risk factors set forth in our Form 10-K, Form 10-Q and Form 8-K reports filed with the Securities and Exchange Commission (including all amendments to those reports) and exhibits to those reports. Except to the extent required by applicable law, we undertake no obligation to update or revise any forward-looking statement to reflect subsequent events or circumstances.
Print Page : Email Page : : Sign up for news : Contact Information : Tear Sheet